• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Will There Ever Be Cure for Chronic, Life-Changing Colistin-Resistant in Urinary Tract Infection?

作者信息

Shein Aye Mya Sithu, Hongsing Parichart, Abe Shuichi, Luk-In Sirirat, Ragupathi Naveen Kumar Devanga, Wannigama Dhammika Leshan, Chatsuwan Tanittha

机构信息

Department of Microbiology, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.

Antimicrobial Resistance and Stewardship Research Unit, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

出版信息

Front Med (Lausanne). 2021 Dec 24;8:806849. doi: 10.3389/fmed.2021.806849. eCollection 2021.

DOI:10.3389/fmed.2021.806849
PMID:35004783
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8740227/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed7/8740227/0044f892566d/fmed-08-806849-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed7/8740227/0044f892566d/fmed-08-806849-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ed7/8740227/0044f892566d/fmed-08-806849-g0001.jpg

相似文献

1
Will There Ever Be Cure for Chronic, Life-Changing Colistin-Resistant in Urinary Tract Infection?对于改变生活的慢性耐黏菌素尿路感染，会有治愈的那一天吗？
Front Med (Lausanne). 2021 Dec 24;8:806849. doi: 10.3389/fmed.2021.806849. eCollection 2021.
2
Emergence of concurrent infections with colistin-resistant ESBL-positive Klebsiella pneumoniae and OXA-23-producing Acinetobacter baumannii sensitive to colistin only in a Romanian cardiac intensive care unit.仅在罗马尼亚一家心脏重症监护病房出现对黏菌素耐药的产超广谱β-内酰胺酶（ESBL）阳性肺炎克雷伯菌与仅对黏菌素敏感的产OXA-23型鲍曼不动杆菌的合并感染。
Eur J Clin Microbiol Infect Dis. 2015 Oct;34(10):2069-74. doi: 10.1007/s10096-015-2453-3. Epub 2015 Aug 4.
3
Evaluation of risk factors for colistin resistance among uropathogenic isolates of Escherichia coli and Klebsiella pneumoniae: a case-control study.评估大肠埃希菌和肺炎克雷伯菌尿路分离株对黏菌素耐药的危险因素：病例对照研究。
J Med Microbiol. 2019 Jun;68(6):837-847. doi: 10.1099/jmm.0.000986. Epub 2019 May 14.
4
Genomic and phylogenetic analysis of a multidrug-resistant mcr-1-carrying Klebsiella pneumoniae recovered from a urinary tract infection in China.中国尿路感染中一株携带 mcr-1 耐药基因的多重耐药肺炎克雷伯菌的基因组和系统进化分析。
J Glob Antimicrob Resist. 2021 Dec;27:222-224. doi: 10.1016/j.jgar.2021.10.002. Epub 2021 Oct 12.
5
Emergence of colistin-resistant Klebsiella pneumoniae in Poland.波兰出现对黏菌素耐药的肺炎克雷伯菌。
Acta Microbiol Immunol Hung. 2019 Dec 9;67(1):18-22. doi: 10.1556/030.66.2019.028.
6
Emergence of the Novel Aminoglycoside Acetyltransferase Variant and Acquisition of Colistin Heteroresistance in Carbapenem-Resistant Due to a Disrupting Mutation in the DNA Repair Enzyme MutS.新型氨基糖苷乙酰转移酶变体的出现及由于 DNA 修复酶 MutS 中的突变导致的多粘菌素异质性耐药获得 碳青霉烯耐药
mBio. 2020 Dec 22;11(6):e01954-20. doi: 10.1128/mBio.01954-20.
7
Genetic Characterisation of Colistin Resistant Clinical Isolates From North India.印度北部耐粘菌素临床分离株的遗传特征。
Front Cell Infect Microbiol. 2021 Jun 21;11:666030. doi: 10.3389/fcimb.2021.666030. eCollection 2021.
8
blaOXA-48 carrying clonal colistin resistant-carbapenem resistant Klebsiella pneumoniae in neonate intensive care unit, India.在印度新生儿重症监护病房中携带blaOXA - 48的克隆性耐黏菌素 - 耐碳青霉烯肺炎克雷伯菌
Microb Pathog. 2016 Nov;100:75-77. doi: 10.1016/j.micpath.2016.09.009. Epub 2016 Sep 10.
9
Klebsiella pneumoniae carbapenemase (KPC) in urinary infection isolates.尿路感染分离株中的肺炎克雷伯菌碳青霉烯酶（KPC）。
Arch Microbiol. 2021 May;203(4):1825-1831. doi: 10.1007/s00203-020-02161-x. Epub 2021 Jan 28.
10
Colistin-resistant Klebsiella pneumoniae bloodstream infection: old drug, bad bug.产碳青霉烯酶肺炎克雷伯菌血流感染：老药遇上“狠角色”。
Arch Microbiol. 2021 Aug;203(6):2999-3006. doi: 10.1007/s00203-021-02289-4. Epub 2021 Mar 27.

引用本文的文献

1
Risk Factors for Multidrug Resistance in Patients Infected with Carbapenem-Resistant : A Nomogram.耐碳青霉烯类感染患者多重耐药的危险因素：列线图
Infect Drug Resist. 2024 Nov 3;17:4833-4841. doi: 10.2147/IDR.S479374. eCollection 2024.
2
First detection of multidrug-resistant and toxigenic Pasteurella aerogenes in sow vaginal discharge: a novel threat to swine health in Thailand.首次在母猪阴道分泌物中检测到多药耐药和产毒化脓性巴斯德菌：泰国猪健康的新威胁。
Sci Rep. 2024 Oct 26;14(1):25510. doi: 10.1038/s41598-024-76428-4.
3
Case Study and Genomic Analysis of a Hypervirulent ST25 Strain in a Liver Cirrhosis Patient.

本文引用的文献

1
Novel colistin-EDTA combination for successful eradication of colistin-resistant Klebsiella pneumoniae catheter-related biofilm infections.新型黏菌素-依地酸组合成功根除耐黏菌素肺炎克雷伯菌导管相关生物膜感染。
Sci Rep. 2021 Nov 4;11(1):21676. doi: 10.1038/s41598-021-01052-5.
2
Occurrence of mcr-mediated colistin resistance in Salmonella clinical isolates in Thailand.泰国临床分离沙门氏菌中 mcr 介导的多粘菌素耐药现象的发生。
Sci Rep. 2021 Jul 8;11(1):14170. doi: 10.1038/s41598-021-93529-6.
3
Rapid Development of Cefiderocol Resistance in Carbapenem-resistant Enterobacter cloacae During Therapy Is Associated With Heterogeneous Mutations in the Catecholate Siderophore Receptor cirA.
一名肝硬化患者中高毒力ST25菌株的病例研究与基因组分析
Infect Drug Resist. 2024 Sep 27;17:4205-4212. doi: 10.2147/IDR.S487700. eCollection 2024.
4
Ceftazidime-Avibactam Combination Therapy versus Monotherapy for the Treatment Carbapenem-Resistant Gram-Negative Bacterial Infections: A Retrospective Observational Study.头孢他啶-阿维巴坦联合治疗与单药治疗耐碳青霉烯类革兰阴性菌感染的回顾性观察研究
Infect Drug Resist. 2024 Mar 29;17:1281-1289. doi: 10.2147/IDR.S452805. eCollection 2024.
5
Interactions and Implications of with Human Immune Responses and Metabolic Pathways: A Comprehensive Review.[具体物质]与人类免疫反应和代谢途径的相互作用及影响：全面综述
Infect Drug Resist. 2024 Feb 3;17:449-462. doi: 10.2147/IDR.S451013. eCollection 2024.
6
Clinical Efficacy and Safety Evaluation of Ceftazidime-Avibactam in the Treatment of Infection: A Retrospective Analysis from a Hospital in China.头孢他啶-阿维巴坦治疗感染的临床疗效与安全性评价：来自中国一家医院的回顾性分析
Infect Drug Resist. 2023 Nov 14;16:7227-7237. doi: 10.2147/IDR.S435882. eCollection 2023.
7
Ca-EDTA restores the activity of ceftazidime-avibactam or aztreonam against carbapenemase-producing infections.钙依地酸可恢复头孢他啶-阿维巴坦或氨曲南对产碳青霉烯酶感染的活性。
iScience. 2023 Jun 28;26(7):107215. doi: 10.1016/j.isci.2023.107215. eCollection 2023 Jul 21.
8
The Efficacy and Influencing Factors of Polymyxin B in High-Level Carbapenem-Resistant Infections.多黏菌素B治疗高水平碳青霉烯类耐药感染的疗效及影响因素
Infect Drug Resist. 2023 Jun 27;16:4177-4187. doi: 10.2147/IDR.S409090. eCollection 2023.
9
Molecular evaluation of aminoglycosides resistance and biofilm formation in clinical isolates: A cross-sectional study.临床分离株中氨基糖苷类耐药性及生物膜形成的分子评估：一项横断面研究。
Health Sci Rep. 2023 May 17;6(5):e1266. doi: 10.1002/hsr2.1266. eCollection 2023 May.
在治疗过程中，产碳青霉烯酶阴沟肠杆菌对头孢他啶的耐药性迅速发展与儿茶酚载体铁载体受体 cirA 中的异质性突变有关。
Clin Infect Dis. 2022 Mar 9;74(5):905-908. doi: 10.1093/cid/ciab511.
4
Healthcare-Associated Infections and Antibiotics Consumption: A Comparison of Point Prevalence Studies and Intervention Strategies.医疗机构相关性感染和抗生素消耗：点患病率研究和干预策略的比较。
Hosp Top. 2021 Jul-Sep;99(3):140-150. doi: 10.1080/00185868.2021.1902758. Epub 2021 Apr 1.
5
Enhanced Antimicrobial and Antibiofilm Effect of New Colistin-Loaded Human Albumin Nanoparticles.新型载黏菌素人白蛋白纳米粒增强抗菌及抗生物膜作用
Antibiotics (Basel). 2021 Jan 8;10(1):57. doi: 10.3390/antibiotics10010057.
6
Synergistic antibacterial effects of colistin in combination with aminoglycoside, carbapenems, cephalosporins, fluoroquinolones, tetracyclines, fosfomycin, and piperacillin on multidrug resistant Klebsiella pneumoniae isolates.多黏菌素与氨基糖苷类、碳青霉烯类、头孢菌素类、氟喹诺酮类、四环素类、磷霉素和哌拉西林联合使用对多重耐药肺炎克雷伯菌的协同抗菌作用。
PLoS One. 2021 Jan 6;16(1):e0244673. doi: 10.1371/journal.pone.0244673. eCollection 2021.
7
Coexistence of With Enhances Biofilm Thickness Through Alginate-Related Extracellular Matrix but Is Attenuated by N-acetyl-l-cysteine.与……共存通过与藻酸盐相关的细胞外基质增加生物膜厚度，但被N-乙酰-L-半胱氨酸减弱。
Front Cell Infect Microbiol. 2020 Nov 24;10:594336. doi: 10.3389/fcimb.2020.594336. eCollection 2020.
8
Combination of Colistin and Azidothymidine Demonstrates Synergistic Activity against Colistin-Resistant, Carbapenem-Resistant .黏菌素与齐多夫定联合使用对耐黏菌素、耐碳青霉烯类细菌具有协同活性。
Microorganisms. 2020 Dec 11;8(12):1964. doi: 10.3390/microorganisms8121964.
9
Rescued chlorhexidine activity by resveratrol against carbapenem-resistant Acinetobacter baumannii via down-regulation of AdeB efflux pump.白藜芦醇通过下调 AdeB 外排泵来恢复对碳青霉烯类耐药鲍曼不动杆菌的氯己定活性。
PLoS One. 2020 Dec 2;15(12):e0243082. doi: 10.1371/journal.pone.0243082. eCollection 2020.
10
Plazomicin: a new aminoglycoside in the fight against antimicrobial resistance.普拉佐米星：一种对抗抗菌药物耐药性的新型氨基糖苷类药物。
Ther Adv Infect Dis. 2020 Sep 4;7:2049936120952604. doi: 10.1177/2049936120952604. eCollection 2020 Jan-Dec.